| Trial ID: | L5630 |
| Source ID: | NCT00332085
|
| Associated Drug: |
Chromium Picolinate
|
| Title: |
Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Chromium Picolinate
|
| Outcome Measures: |
Primary: Safety/Adverse Events|Hemoglobin A1c | Secondary: Fasting Blood Glucose, Fasting Insulin, HOMA Index|Lipid Profile: total cholesterol, LDL, HDL, Triglycerides|Oral Glucose Tolerance Test
|
| Sponsor/Collaborators: |
Sponsor: Bastyr University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-01
|
| Completion Date: |
2007-03
|
| Results First Posted: |
|
| Last Update Posted: |
2007-10-31
|
| Locations: |
Bastyr University Campus SPR, Kenmore, Washington, 98036, United States|Bastyr Center for Natural Health, Seattle, Washington, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00332085
|
